[Treatment of postoperative pancreatitis, in patients undergoing cholecystectomy for cholelithiasis].
In the prevention of exacerbations of chronic pancreatitis 28 patients in the early period and one month after cholecystectomy were appointed by octreotide. In assessing the effectiveness of treatment, along with the general clinical data, used a number of modern laboratory instrumentation, ultrasound and biochemical studies. Comprehensive studies have shown that octreotide has a positive impact on the rehabilitation of patients after cholecystectomy, prevents the progression of inflammation and systemic complications.
Ia M
IaM
Vakhrushev
N S
NS
Kropacheva
D002763:Cholecystectomy / Q000009:adverse effects*; D002769:Cholelithiasis / Q000601:surgery*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D010195:Pancreatitis / Q000188:drug therapy* / Q000209:etiology; D011183:Postoperative Complications / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D005765:Gastrointestinal Agents; D015282:Octreotide